Manufacturer
Oncotec Pharma Produktion GmbH(GERMANY)
Registraction Number
MAL15045157ACRZ
Content:
Each vial contains:
-Bendamustine hydrochloride: 100 mg
-Mannitol: 120 mg
Indications:
-Chronic Lymphocytic Leukemia (CLL): Used for the treatment of patients with CLL.
-Non-Hodgkin Lymphoma (NHL): Used for the treatment of patients with indolent NHL that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
-Multiple Myeloma: Used for the treatment of patients with multiple myeloma.
Instructions:
Dosage: The dosage varies based on the patient's condition and response. It is typically administered by a healthcare professional.
Administration:
-Reconstitute the powder with 40 mL of water for injection.
-Further dilute with physiological saline (0.9%).
-Administer by intravenous infusion over 30-60 minutes.
Malaysia
